Volume 27 | November 6, 2024
Did you know that osteosarcoma is one of the more common cancers in dogs, with an estimated 10x incident rate compared to humans? For November Pet Cancer Awareness Month, we spotlight the Flint Animal Cancer Center at Colorado State University, home of the One Cure founding principle that treatment breakthroughs come through collaborations between scientists and doctors who are working with pets and people.
Our furry companions not only bring us joy and comfort, but they are truly our partners in advancing treatments and improving outcomes for all osteosarcoma patients.
Inspired by our companions for a cause, we invite you to Make It Pawsitively Better with us this month:
- OutBark Osteoarcoma with us! Purchase a fashionable bandana for your dog and enter your dog into a paw-some photo contest. All proceeds benefit osteosarcoma patient programs and research.
- Order stunning holiday cards with original artwork by OsteoWarriors. Send one to your dog!
- Help us send holiday cheer to OsteoWarriors - shop a curated list of gifts for our Warrior Mail holiday shipment.
- Join the CURE-OS working group, and collaborate with colleagues in the study of canine and human osteosarcoma heterogeneity by single cell technologies.
Thank you for being part of our pack.
With hope and gratitude,
Ann
.png)
.png)
With a $16 donation, your dog can proudly wear a gold MIB dog bandana, helping to raise awareness for osteosarcoma, which has an estimated 10x higher incidence in dogs than in humans. Enter our "Who Wore It Best" photo competition by taking a picture of your dog in the bandana and creating a fundraising page to share their story. Encourage your friends and family to vote for your furry friend—each vote is a $5 donation that Makes It Better for kids and pups facing osteosarcoma. Together, we’re building hope, one wag and one vote at a time. Share your photos on your fundraiser page, and be sure to tag us with #OutBarking!
.png)
Showcase the heartfelt talent of six beloved MIB OsteoWarriors with each stunning, original artwork. Every box includes 12 beautifully designed cards and 13 envelopes, perfect for sharing joy this season. Only $24 with FREE Shipping!
November is Pet Cancer Awareness Month, a time to reflect on the challenges faced by our furry companions battling this disease and how they help make it better for human osteosarcoma patients. The incidence of osteosarcoma in dogs is estimated to be ten times higher than in humans, underscoring the importance of comparative oncology, where insights gained from veterinary cases can significantly advance our understanding and treatment of cancer in human patients. This month we spotlight the Flint Animal Cancer Center at Colorado State University, a leading institution dedicated to the study and treatment of cancer in animals. Their innovative research and clinical practices not only aim to improve outcomes for pets but also hold potential to unlock breakthroughs that can benefit human patients. Doug Thamm, VMD and Dan Regan, DVM, PhD lead the clinical and research programs respectively and they share with us the philosophy behind the One Cure goal to improve the prevention, diagnosis, and treatment of cancer in pets and then use that research and knowledge to also benefit people with cancer.
Learn More About the Flint Animal Cancer Center
- Program Head, Sarcoma - Fred Hutchinson Cancer Center: Clinical Research Division
- Medical Oncology, Sarcoma Oncology Clinical Faculty - Cedars Sinai
- Medical Oncologist, Sarcoma - Mayo Clinic
- Asst or Assoc Professor, Sarcoma Oncology - Fred Hutchinson Cancer Center
- Orthopaedic Oncologist - Ochsner Health
- Clinical Faculty, Solid Tumor Focus - Riley Children's Health
- Associate Professor or Professor, Tenure Track, Pediatric Sarcoma Research - UPenn
- Associate or Full Professor (Program Head, Sarcoma Program) - UW
- Postdoctoral Fellow, Sarcoma Medical Oncology - MDACC
- Assistant Professor, Sarcoma - OHSU
- Sarcoma Oncologist - Georgetown Cancer Institute
- Pediatric Oncology Solid Tumor Clinician Educator - Stanford
If you have a job posting and you would like it included here, please email christina@mibagents.org.
.png)
.png)
.png)
.png)
Watch Past Episodes and See the Upcoming Schedule
- Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis
Send Holiday Cheer to OsteoWarriors
Learn about Canine Osteosarcoma Trials
CURE-OS (Collaborative Understanding of the Range and Evolution of Osteosarcoma Single-cells) is an international working group dedicated to the study of heterogeneity in osteosarcoma by single cell technologies. By sharing knowledge and establishing standards for the collection, analysis, and dissemination of single cell data in osteosarcoma, the group's goal is to advance osteosarcoma single cell research toward improving the care of OS patients by:
- Disseminating knowledge and facilitate collaborative research through expert talks.
- Developing an international consensus on key goals and standards for osteosarcoma single cell research to support a unified osteosarcoma atlas in support of future studies.
- Creating a shared repository for osteosarcoma single cell research data and methodologies.
The group is open to anyone interested in the study of osteosarcoma heterogeneity by single cell technologies.
Join the CURE-OS Working Group
If you have a trial that is currently enrolling osteosarcoma patients, please email christina@mibagents.org.
.jpeg)
